World's First Viable Malaria Vaccine Shows Success in Trials

April 24, 2015 12:32 PM

1 0

The results of final clinical trials of the first viable malaria vaccine show it offers partial protection against malaria for up to four years. The vaccine is called RTS,S and has been developed over two decades by GlaxoSmithKline and a non-profit organization funded by the Bill & Melinda Gates Foundation.

It is designed for children in African countries and if approved by international regulators, like the World Health Organization, it could be made available for use in Africa from October.

Read more

To category page